科技部: H7N9 病毒疫苗种子株研制成功

2018-03-28 佚名 央视网

27 日上午,科技部发布“艾滋病和病毒性肝炎等重大传染病防治”科技重大专项成果。我国流感防控科技创新能力取得重大突破,我国首个 H7N9 病毒疫苗种子株成功研制。

27 日上午,科技部发布“艾滋病和病毒性肝炎等重大传染病防治”科技重大专项成果。我国流感防控科技创新能力取得重大突破,我国首个 H7N9 病毒疫苗种子株成功研制

国家卫生健康委员会科教司监察专员刘登峰指出,重大专项实施 10 年来,我国突破一批制约艾滋病、乙肝、结核病诊、防、治的关键技术,使重大突发疫情实现了从被动应付到主动应对的转变,总体达到国际先进水平。

传染病专项技术副总师、中国工程院院士徐建国介绍说,我国流感监测网络自 2000 年系统建立完善,至今已覆盖了全国 31 个省,554 家流感监测哨点医院,408 家流感监测网络实验室,并实时监测流感的流行强度,实时分析流感病毒的抗原性、耐药性和基因特性,及时发现变异病毒。

传染病专项技术副总师、中国工程院院士 徐建国:建立了七十二小时之内筛查监测 300 种已知病原体的技术支持体系,和 15 小时内完成常见病原体现场检测等多种综合检测方法体系,建立了多项具有自主知识产权,并投入实际应用的尖端检测技术。

目前,我国流感防控科技创新能力取得重大突破。在专项支持下,研发人感染 H7N9 禽流感病毒快速检测试剂,并通过世界卫生组织与全球共享;研制我国首个 H7N9 病毒疫苗种子株,打破了我国流感疫苗株必须依赖国际提供的历史。目前,我国还支持新型四价流感疫苗并申报审批,并有望在今年上市。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1800946, encodeId=fc3a180094622, content=<a href='/topic/show?id=66dfe332390' target=_blank style='color:#2F92EE;'>#研制成功#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73323, encryptionId=66dfe332390, topicName=研制成功)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Oct 29 19:51:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083296, encodeId=eb1c208329608, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Wed Jan 23 00:51:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802069, encodeId=0a2f180206997, content=<a href='/topic/show?id=91c9e4774bc' target=_blank style='color:#2F92EE;'>#种子株#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74774, encryptionId=91c9e4774bc, topicName=种子株)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Jan 06 22:51:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477555, encodeId=936014e75554e, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487686, encodeId=3efd148e6869e, content=<a href='/topic/show?id=c00de49752c' target=_blank style='color:#2F92EE;'>#科技部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74975, encryptionId=c00de49752c, topicName=科技部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe118348559, createdName=liubm558, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300721, encodeId=27fd300e2129, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Mar 29 06:49:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300476, encodeId=86103004e6c1, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 28 09:02:21 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1800946, encodeId=fc3a180094622, content=<a href='/topic/show?id=66dfe332390' target=_blank style='color:#2F92EE;'>#研制成功#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73323, encryptionId=66dfe332390, topicName=研制成功)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Oct 29 19:51:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083296, encodeId=eb1c208329608, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Wed Jan 23 00:51:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802069, encodeId=0a2f180206997, content=<a href='/topic/show?id=91c9e4774bc' target=_blank style='color:#2F92EE;'>#种子株#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74774, encryptionId=91c9e4774bc, topicName=种子株)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Jan 06 22:51:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477555, encodeId=936014e75554e, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487686, encodeId=3efd148e6869e, content=<a href='/topic/show?id=c00de49752c' target=_blank style='color:#2F92EE;'>#科技部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74975, encryptionId=c00de49752c, topicName=科技部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe118348559, createdName=liubm558, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300721, encodeId=27fd300e2129, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Mar 29 06:49:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300476, encodeId=86103004e6c1, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 28 09:02:21 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1800946, encodeId=fc3a180094622, content=<a href='/topic/show?id=66dfe332390' target=_blank style='color:#2F92EE;'>#研制成功#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73323, encryptionId=66dfe332390, topicName=研制成功)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Oct 29 19:51:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083296, encodeId=eb1c208329608, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Wed Jan 23 00:51:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802069, encodeId=0a2f180206997, content=<a href='/topic/show?id=91c9e4774bc' target=_blank style='color:#2F92EE;'>#种子株#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74774, encryptionId=91c9e4774bc, topicName=种子株)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Jan 06 22:51:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477555, encodeId=936014e75554e, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487686, encodeId=3efd148e6869e, content=<a href='/topic/show?id=c00de49752c' target=_blank style='color:#2F92EE;'>#科技部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74975, encryptionId=c00de49752c, topicName=科技部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe118348559, createdName=liubm558, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300721, encodeId=27fd300e2129, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Mar 29 06:49:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300476, encodeId=86103004e6c1, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 28 09:02:21 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
    2019-01-06 lfyang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1800946, encodeId=fc3a180094622, content=<a href='/topic/show?id=66dfe332390' target=_blank style='color:#2F92EE;'>#研制成功#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73323, encryptionId=66dfe332390, topicName=研制成功)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Oct 29 19:51:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083296, encodeId=eb1c208329608, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Wed Jan 23 00:51:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802069, encodeId=0a2f180206997, content=<a href='/topic/show?id=91c9e4774bc' target=_blank style='color:#2F92EE;'>#种子株#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74774, encryptionId=91c9e4774bc, topicName=种子株)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Jan 06 22:51:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477555, encodeId=936014e75554e, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487686, encodeId=3efd148e6869e, content=<a href='/topic/show?id=c00de49752c' target=_blank style='color:#2F92EE;'>#科技部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74975, encryptionId=c00de49752c, topicName=科技部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe118348559, createdName=liubm558, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300721, encodeId=27fd300e2129, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Mar 29 06:49:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300476, encodeId=86103004e6c1, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 28 09:02:21 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1800946, encodeId=fc3a180094622, content=<a href='/topic/show?id=66dfe332390' target=_blank style='color:#2F92EE;'>#研制成功#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73323, encryptionId=66dfe332390, topicName=研制成功)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Oct 29 19:51:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083296, encodeId=eb1c208329608, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Wed Jan 23 00:51:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802069, encodeId=0a2f180206997, content=<a href='/topic/show?id=91c9e4774bc' target=_blank style='color:#2F92EE;'>#种子株#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74774, encryptionId=91c9e4774bc, topicName=种子株)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Jan 06 22:51:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477555, encodeId=936014e75554e, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487686, encodeId=3efd148e6869e, content=<a href='/topic/show?id=c00de49752c' target=_blank style='color:#2F92EE;'>#科技部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74975, encryptionId=c00de49752c, topicName=科技部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe118348559, createdName=liubm558, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300721, encodeId=27fd300e2129, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Mar 29 06:49:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300476, encodeId=86103004e6c1, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 28 09:02:21 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1800946, encodeId=fc3a180094622, content=<a href='/topic/show?id=66dfe332390' target=_blank style='color:#2F92EE;'>#研制成功#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73323, encryptionId=66dfe332390, topicName=研制成功)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Oct 29 19:51:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083296, encodeId=eb1c208329608, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Wed Jan 23 00:51:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802069, encodeId=0a2f180206997, content=<a href='/topic/show?id=91c9e4774bc' target=_blank style='color:#2F92EE;'>#种子株#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74774, encryptionId=91c9e4774bc, topicName=种子株)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Jan 06 22:51:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477555, encodeId=936014e75554e, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487686, encodeId=3efd148e6869e, content=<a href='/topic/show?id=c00de49752c' target=_blank style='color:#2F92EE;'>#科技部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74975, encryptionId=c00de49752c, topicName=科技部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe118348559, createdName=liubm558, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300721, encodeId=27fd300e2129, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Mar 29 06:49:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300476, encodeId=86103004e6c1, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 28 09:02:21 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
    2018-03-29 yfjms

    学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1800946, encodeId=fc3a180094622, content=<a href='/topic/show?id=66dfe332390' target=_blank style='color:#2F92EE;'>#研制成功#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73323, encryptionId=66dfe332390, topicName=研制成功)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Mon Oct 29 19:51:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083296, encodeId=eb1c208329608, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Wed Jan 23 00:51:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802069, encodeId=0a2f180206997, content=<a href='/topic/show?id=91c9e4774bc' target=_blank style='color:#2F92EE;'>#种子株#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74774, encryptionId=91c9e4774bc, topicName=种子株)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Jan 06 22:51:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477555, encodeId=936014e75554e, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487686, encodeId=3efd148e6869e, content=<a href='/topic/show?id=c00de49752c' target=_blank style='color:#2F92EE;'>#科技部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74975, encryptionId=c00de49752c, topicName=科技部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe118348559, createdName=liubm558, createdTime=Thu Mar 29 23:51:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300721, encodeId=27fd300e2129, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Mar 29 06:49:00 CST 2018, time=2018-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300476, encodeId=86103004e6c1, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 28 09:02:21 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
    2018-03-28 wzb521zf

    一起学习学习

    0

相关资讯

广东报告2018年首例H7N9病例

2018年广东省报告H7N9病例1例。

云南省卫计委通报 确诊1例H7N9病例

云南省卫生计生委通报:11月30日,确诊1例H7N9病例。患者,男,64岁,现住昆明寻甸县,家中养鸡10余只,发病前自家养的鸡有相继死亡现象,有活鸡、死鸡及鸡粪接触史。目前,患者在医院隔离治疗。所有与该患者密切接触者未出现异常,未发现人传人。疫情发生后,云南省卫生计生委和昆明市政府及时调集省市专家全力救治患者,开展疫情处置工作。专家建议,公众在日常生活中应避免接触病死禽,尽量避免直接接触活禽;若发

Cell Host & Microbe:疾控中心舒跃龙团队等追踪H7N9禽流感流行潜力

2013年3月,中国首次报告了人感染H7N9禽流感病毒病例。截至10月5日,世界卫生组织已收到世界各地千余例经实验室确诊的病例报告。近日,一个跨国研究团队在《细胞—宿主和微生物》期刊上发文称,高致病性禽流感(HPAI)H7N9病毒在人类气道细胞和动物模型的肺中能有效复制,并通过呼吸飞沫在雪貂之间传播,而且对常用的抗病毒药物反应极低。

Mol Ther Nucleic Acids:内源microRNA组成的抗流感病毒防御体系

近年来,季节性流感高发,而且禽流感不断跨越物种屏障感染人,特别是H7N9和高致病性禽流感H5N1疫情时有发生,不仅严重威胁人类健康,而且给畜牧业生产造成重大损失,已成为严重的公共卫生问题。目前人类对流感病毒感染尚没有有效疗法。鉴于近两年流感病毒频繁暴发,所以研发有效抑制流感病毒感染的方法就显得尤为重要。

复旦大学揭示H7N9感染重症化机制

复旦大学生物医学研究院/上海市公共卫生临床中心双聘教授徐建青领导的团队发现,急性重症流感如H7N9可导致CD8+T细胞功能耗竭,从而影响流感的感染康复。相关成果日前发表于《自然—通讯》杂志。2013年新发现的禽源重组流感病毒H7N9致病率高、病情严重,且致死率高(大于40%),从而引起全球高度关注。徐建青团队前期的研究发现,死亡病例不能产生有效的分泌干扰素的T细胞,但其中的机制尚未明确。最新研究发

Nat Commun:H7N9感染重症化“奥秘”被发现:流感特异性CD8+T细胞早期扩增

近日,复旦大学附属上海市公共卫生临床中心、复旦大学生物医学研究院双聘教授徐建青临床研究团队与澳大利亚墨尔本大学合作,带领博士后王忠芳和朱凌燕的一项研究表明,急性重症禽流感H7N9 可导致体内CD8+T细胞功能耗竭,从而影响H7N9感染康复。